Dihexa 50mg — Vial Spec, Reconstitution Math & COA

Dihexa 50mg Vial Overview & Laboratory Availability

A 50mg vial of Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) represents an expanded material mass designed for institutional research laboratories conducting multi-plate cellular assays or extended preclinical animal models. In cell culture and biochemical research, this mass allows investigators to prepare standardized stock solutions without the inter-assay variability introduced by opening multiple lower-mass vials across a single experimental timeline.

While a 50mg lyophilized powder configuration provides maximum flexibility for custom solubilization protocols, researchers should evaluate their laboratory's immediate consumption rate and solvent capabilities before selecting this mass. PX1 Research prioritizes rigorous quality standards across all formats, ensuring that every batch meets target purity benchmarks verified by independent testing.

Please note: PX1 Research periodically adjusts vial fill configurations based on institutional demand. If the 50mg single-vial format is currently out of stock or unlisted, laboratories can review alternative high-purity specifications such as our Dihexa Capsules 10mg for solid-state handling or explore our complete catalog of all peptides for alternative research compounds.

Chemical Identity, Receptor Kinase Target, and Preclinical Mechanism

Dihexa is an oligopeptide derivative synthesized from angiotensin IV (Ang IV) that exhibits sub-nanomolar affinity for hepatocyte growth factor (HGF) and its receptor tyrosine kinase, c-Met. In preclinical neurobiology models, binding of Dihexa to HGF facilitates the dimerization of the c-Met receptor, triggering downstream autophosphorylation and initiating intracellular signaling cascades including the MAPK/ERK and PI3K/Akt pathways.

In vitro data indicate that this activation promotes robust dendritic arborization, spinogenesis, and synaptogenesis in cultured hippocampal and cortical neurons at picomolar concentrations. Unlike native HGF, which is a large polypeptide with limited stability, Dihexa was engineered as a low-molecular-weight compound capable of crossing biological membranes and remaining metabolically stable in serum assays.

Preclinical rodent models investigating cognitive impairment and neurodegenerative paradigms suggest that Dihexa-induced c-Met activation enhances synaptic connectivity and functional plasticity. Researchers studying synaptogenesis, focal cerebral ischemia models, or receptor-ligand interactions utilize Dihexa to map structural remodeling at the neuronal spine level.

Solubility Dynamics & Reconstitution Mechanics for 50mg Mass

Reconstituting a 50mg vial of Dihexa requires careful attention to the compound's chemical structure. Due to its hexanoyl N-terminal modification and hydrophobic amino acid residue chain, Dihexa exhibits limited aqueous solubility compared to hydrophilic peptides. Attempting direct dissolution in pure bacteriostatic water or standard phosphate-buffered saline (PBS) at high concentrations often results in persistent suspension or precipitation.

To achieve complete solubilization at a 50mg scale, laboratories frequently employ a primary organic co-solvent approach. Dimethyl sulfoxide (DMSO) or polyethylene glycol (PEG400) is routinely utilized to establish a concentrated master stock solution before diluting into final aqueous assay media. A common protocol involves dissolving the 50mg powder in 100% sterile DMSO to create a high-concentration primary stock (e.g., 50 mg/mL), followed by serial dilution into biological buffers ensuring the final organic solvent concentration remains below the toxicity threshold of the specific cell line or assay system (typically <0.1% to 0.5% v/v DMSO).

When aqueous reconstitution is strictly required, gentle vortexing combined with mild ultrasonic water bath treatment at ambient room temperature (20°C–22°C) may assist dissolution, though concentration limits will be significantly lower than organic-assisted methods. Avoid excessive heating above 37°C during dissolution to prevent thermal degradation of the peptide matrix.

Reconstitution Mathematics: 1mL, 2mL, and 3mL Diluent Volume Calculations

Accurate concentration calculations are vital when preparing stock solutions from a 50mg material vial. The total mass (50mg) divided by the added liquid volume dictates the resulting working concentration. To streamline laboratory calculations, utilize the following volumetric standards or verify complex working dilutions using our online reconstitution calculator.

Addition of 1.0 mL Diluent: Yields a concentration of 50.0 mg/mL (50,000 µg/mL). This high-density concentration is ideal for creating compact master stocks intended for subsequent high-fold dilution into cell culture media or micro-aliquot freezing.

Addition of 2.0 mL Diluent: Yields a concentration of 25.0 mg/mL (25,000 µg/mL). This moderate density provides a balanced volumetric margin, allowing precise pipette transfer of intermediate working doses without excessive viscous displacement.

Addition of 3.0 mL Diluent: Yields a concentration of 16.67 mg/mL (16,667 µg/mL). This concentration is frequently selected when larger working volumes are required for immediate multi-well plate dispensing where micro-pipetting errors must be minimized.

Aliquot Management & Freeze-Thaw Degradation Mitigation

Once a 50mg vial is reconstituted into liquid stock, subjecting the solution to repeated freeze-thaw cycles significantly accelerates molecular degradation, peptide aggregation, and loss of biological activity. Institutional standard operating procedures (SOPs) mandate immediate sub-aliquoting upon initial dissolution.

Following reconstitution, the working stock should be divided into sterile, low-protein-binding microcentrifuge tubes in single-use volumes tailored to specific assay batch sizes (e.g., 50 µL to 200 µL per tube). Tubes must be tightly sealed, labeled with lot number, concentration, solvent vehicle, and date of reconstitution, and immediately stored at -20°C or -80°C.

For long-term storage, -80°C ultralow refrigeration prevents ice crystal migration and chemical breakdown. When preparing an aliquot for an experimental run, thaw the tube rapidly at room temperature, vortex briefly, centrifuge to collect condensation from the cap, and use immediately. Unused portions of thawed aliquots should be discarded rather than re-frozen.

Comparative Analysis: Dihexa vs. Alternative Synaptogenic and Neuro-Active Research Peptides

When designing neurobiological investigations, researchers often compare Dihexa against other small-molecule peptides and central nervous system targets to select the optimal tool for their structural or functional endpoints.

In synaptic plasticity research, Dihexa is evaluated alongside compounds such as Semax, Selank, and systemic repair peptides like BPC-157. While Semax and Selank act predominantly via melanocortin receptor activation, neurotrophin modulation (BDNF/NGF induction), and neurotransmitter metabolic signaling, Dihexa operates via a distinct direct enzymatic pathway by acting as a high-affinity c-Met receptor agonist. Conversely, compounds like BPC-157 are investigated primarily for cytoprotective and focal tissue repair pathways rather than central dendritic spinogenesis. Understanding these mechanistic differences allows investigators to select the appropriate compound class based on whether their hypothesis centers on kinase-driven structural synaptogenesis, neurotrophin expression, or systemic cytoprotection.

Analytical QC Verification: HPLC, Mass Spectrometry, and Endotoxin Limits

PX1 Research enforces stringent quality control protocols on every production batch to guarantee that experimental results reflect true molecular activity without artifactual interference from impurities or bacterial contaminants.

Purity is quantified using High-Performance Liquid Chromatography (HPLC) coupled with UV detection. Each batch must achieve an HPLC purity rating of ≥98.0%, ensuring the absence of truncated peptide sequences, unreacted synthesis reagents, or residual side-products. Mass Spectrometry (MS) is simultaneously performed to verify the exact molecular mass and identity of the chemical structure.

Furthermore, because cellular assays and primary neuronal cultures are highly sensitive to pyrogenic contamination, PX1 Research subjects raw materials to Limulus Amebocyte Lysate (LAL) testing to confirm low endotoxin levels (<0.5 EU/mg). Laboratories can inspect and download lot-matched documentation directly from our COA database.

Laboratory Storage Protocols & Lyophilized Powder Shelf Life

Proper storage conditions are critical to maintaining the chemical integrity of Dihexa powder prior to and following reconstitution. Lyophilized (freeze-dried) powder supplied in sealed vials exhibits optimal stability when stored in a desiccated environment at -20°C for mid-term research (up to 24 months) or -80°C for extended archival storage.

Vials stored at standard refrigerated temperatures (2°C to 8°C) should be utilized within 30 to 60 days. Prior to opening a cold lyophilized vial, allow the container to equilibrate to room temperature on the laboratory bench for 30–45 minutes. Opening a cold vial in ambient air causes immediate condensation of atmospheric moisture onto the lyophilized cake, which introduces water contamination and induces premature hydrolysis.

Reconstituted liquid solutions stored in organic solvents (such as 100% DMSO) remain stable at -20°C for up to 6 months, whereas aqueous or buffered working dilutions should be stored at 2°C to 8°C and consumed within 7 to 14 days.

Selecting Format Sizes: 50mg Bulk Vials vs. Alternative Material Quantities

Choosing between a 50mg vial and smaller unit sizes depends on trial scale, solvent handling infrastructure, and assay repetition frequencies. A 50mg format offers significant cost efficiency per milligram for high-throughput screening platforms, automated fluid handlers, and multi-animal rodent cohorts requiring uniform reagent lots.

However, for small-scale exploratory pilot studies, single-cell electrophysiology recordings, or assays where solvent preparation equipment is restricted, smaller unit mass configurations or specialized pre-measured formats may prevent reagent waste. Researchers interested in evaluating alternative delivery or handling designs for cellular uptake studies can explore related resources in our research library.

Evaluating trial design against reagent stability profiles ensures that laboratories select the optimal packaging format, minimizing unnecessary freeze-thaw degradation while securing adequate material for statistically powered experimental runs.

Institutional Sourcing, ISO 17025 Compliance, and Wholesale Procurement

PX1 Research operates as a premier supplier of high-purity research compounds for academic institutions, biotechnology firms, and contract research organizations (CROs). All peptide synthesis and lyophilization procedures are conducted in state-of-the-art USA-based facilities adhering to GMP-compliant quality management standards.

Every batch undergoes comprehensive testing in an ISO 17025 accredited laboratory, ensuring complete traceability from raw chemical precursors to final packaged vials. We provide same-day shipping for orders placed Monday through Friday, operating directly out of our dual fulfillment hubs in California and Arizona.

For principal investigators and laboratory procurement managers requiring large-volume custom fills, multi-gram quantities, or institutional billing accounts, visit our wholesale portal to consult with our technical support team regarding custom synthesis and volume contract pricing.